Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 5 (2008), Issue 3 (March)

1. Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma.
   Cancer, 112(5): 1131-8. [Abstract] [Full-text]
2. Practical guidelines for the management of interferon-alpha-2b side effects in patients receiving adjuvant treatment for melanoma: expert opinion.
   Cancer, 112(5): 982-94. [Abstract] [Full-text]
3. Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.
   Cancer, 112(5): 1147-52. [Abstract] [Full-text]
4. Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region.
   Am J Med Genet A, 146(6): 691-9. [Abstract] [Full-text]
5. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: a case-control study.
   Int J Cancer, 122(9): 2077-84. [Abstract] [Full-text]
6. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor.
   Int J Cancer, 122(9): 1972-80. [Abstract] [Full-text]
7. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
   Histopathology, 52(4): 500-9. [Abstract] [Full-text]
8. Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.
   Cancer Res, 68(5): 1254-60. [Abstract] [Full-text]
9. Sentinel lymph node status is the most important prognostic factor for thick (> or = 4 mm) melanomas.
   J Dtsch Dermatol Ges, 6(3): 198-203. [Abstract] [Full-text]
10. Installation of a network for patients with congenital melanocytic nevi in German-speaking countries.
    J Dtsch Dermatol Ges, 6(3): 204-8. [Abstract] [Full-text]
11. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.
    Exp Dermatol, 17(4): 349-55. [Abstract] [Full-text]
12. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.
    Am J Transplant, 8(4): 877-80. [Abstract] [Full-text]
13. Merkel cell carcinoma: a review of management.
    Curr Opin Otolaryngol Head Neck Surg, 16(2): 170-4. [Abstract] [Full-text]
14. Liver resection-associated macrophage inflammatory protein-2 stimulates engraftment but not growth of colorectal metastasis at extrahepatic sites.
    J Surg Res, 145(2): 295-302. [Abstract] [Full-text]
15. A suprapubic dermoid cyst confused with cutaneous endometriosis: a case report.
    Fertil Steril, 89(3): 724.e5-7. [Abstract] [Full-text]
16. Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma.
    Arch Intern Med, 168(5): 501-7. [Abstract] [Full-text]
17. TNF-based isolated limb perfusion followed by consolidation biotherapy with systemic low-dose interferon alpha 2b in patients with in-transit melanoma metastases: a pilot trial.
    Ann Surg Oncol, 15(4): 1218-23. [Abstract] [Full-text]
18. Compliance with melanoma treatment guidelines in a community teaching hospital: time trends and other variables.
    Ann Surg Oncol, 15(4): 1211-7. [Abstract] [Full-text]
19. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
    Ann Surg Oncol, 15(4): 1202-10. [Abstract] [Full-text]
20. Atypical distinctive dermal clear cell mesenchymal neoplasm arising in the scalp.
    J Cutan Pathol, 35(4): 423-7. [Abstract] [Full-text]
21. Skin metastasis from typical carcinoid tumor of the lung.
    J Cutan Pathol, 35(4): 418-22. [Abstract] [Full-text]
22. Histopathologic findings and diagnostic difficulties posed with use of escharotic agents for treatment of skin lesions: a case report and review of the literature.
    J Cutan Pathol, 35(4): 404-6. [Abstract] [Full-text]
23. Diagnostic concordance among dermatopathologists using a three-tiered keratinocytic intraepithelial neoplasia grading scheme.
    J Cutan Pathol, 35(4): 386-91. [Abstract] [Full-text]
24. SOX9 expression is a general marker of basal cell carcinoma and adnexal-related neoplasms.
    J Cutan Pathol, 35(4): 373-9. [Abstract] [Full-text]
25. Ber-EP4 enhances the differential diagnostic accuracy of cytokeratin 7 in pagetoid cutaneous neoplasms.
    J Cutan Pathol, 35(4): 366-72. [Abstract] [Full-text]
26. Squamous cell carcinomas with single cell infiltration: a potential diagnostic pitfall and the utility of MNF116 and p63.
    J Cutan Pathol, 35(4): 353-7. [Abstract] [Full-text]
27. Discordance in the histopathologic diagnosis of difficult melanocytic neoplasms in the clinical setting.
    J Cutan Pathol, 35(4): 349-52. [Abstract] [Full-text]
28. CD20 positive mycosis fungoides: a case report.
    J Cutan Pathol, 35(4): 398-403. [Abstract] [Full-text]
29. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
    Carcinogenesis, 29(3): 455-65. [Abstract] [Full-text]
30. TCRgamma-chain gene rearrangement by PCR-based GeneScan: diagnostic accuracy improvement and clonal heterogeneity analysis in multiple cutaneous T-cell lymphoma samples.
    J Invest Dermatol, 128(4): 1030-8. [Abstract] [Full-text]
31. Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells.
    J Invest Dermatol, 128(4): 949-56. [Abstract] [Full-text]
32. Expression of ligands to NKp46 in benign and malignant melanocytes.
    J Invest Dermatol, 128(4): 972-9. [Abstract] [Full-text]
33. Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma.
    J Invest Dermatol, 128(4): 988-98. [Abstract] [Full-text]
34. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
    J Invest Dermatol, 128(4): 957-71. [Abstract] [Full-text]
35. mTOR is activated in the majority of malignant melanomas.
    J Invest Dermatol, 128(4): 980-7. [Abstract] [Full-text]
36. Chronic diseases requiring hospitalization and risk of non-melanoma skin cancers--a population based study from Denmark.
    J Invest Dermatol, 128(4): 926-31. [Abstract] [Full-text]
37. Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
    Am J Surg Pathol, 32(3): 354-62. [Abstract] [Full-text]
38. Cutaneous fetal rhabdomyoma: a case report and historical review of the literature.
    Am J Surg Pathol, 32(3): 485-91. [Abstract] [Full-text]
39. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice.
    J Pineal Res, 44(3): 307-15. [Abstract] [Full-text]
40. Mycosis fungoides and Sézary syndrome.
    Lancet, 371(9616): 945-57. [Abstract] [Full-text]
41. Reactive eccrine syringofibroadenoma arising in peristomal skin: An unusual presentation of a rare lesion.
    J Am Acad Dermatol, 58(4): 691-6. [Abstract] [Full-text]
42. Pagetoid reticulosis in a 5-year-old boy.
    J Am Acad Dermatol, 58(4): 679-81. [Abstract] [Full-text]
43. Cutaneous plasmablastic lymphoma.
    J Am Acad Dermatol, 58(4): 676-8. [Abstract] [Full-text]
44. Primary cutaneous adenoid cystic carcinoma.
    J Am Acad Dermatol, 58(4): 636-41. [Abstract] [Full-text]
45. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
    J Am Acad Dermatol, 58(4): 592-5. [Abstract] [Full-text]
46. Imiquimod 5% cream for treatment of HIV-negative Kaposi's sarcoma skin lesions: A phase I to II, open-label trial in 17 patients.
    J Am Acad Dermatol, 58(4): 585-91. [Abstract] [Full-text]
47. Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes.
    Photodermatol Photoimmunol Photomed, 24(2): 87-94. [Abstract] [Full-text]
48. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo?
    Photodermatol Photoimmunol Photomed, 24(2): 72-5. [Abstract] [Full-text]
49. A pilot study of fluorescence diagnosis of basal cell carcinoma using a digital flash light-based imaging system.
    Photodermatol Photoimmunol Photomed, 24(2): 67-71. [Abstract] [Full-text]
50. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids.
    Virology, 373(2): 352-61. [Abstract] [Full-text]
51. Papular elastorrhexis, a distinctive entity?
    Am J Dermatopathol, 30(2): 188-90. [Abstract] [Full-text]
52. Melanoma with second myxoid stromal changes after personally applied prolonged phototherapy.
    Am J Dermatopathol, 30(2): 185-7. [Abstract] [Full-text]
53. Identical twins with primary cutaneous melanoma presenting at the same time and location.
    Am J Dermatopathol, 30(2): 182-4. [Abstract] [Full-text]
54. Complete regression of primary malignant melanoma.
    Am J Dermatopathol, 30(2): 178-81. [Abstract] [Full-text]
55. An unusual composite pilomatrix carcinoma with intralesional melanocytes: differential diagnosis, immunohistochemical evaluation, and review of the literature.
    Am J Dermatopathol, 30(2): 174-7. [Abstract] [Full-text]
56. Erythema nodosum in association with newly diagnosed hairy cell leukemia and group C streptococcus infection.
    Am J Dermatopathol, 30(2): 160-2. [Abstract] [Full-text]
57. Primitive nonneural granular cell tumor (so-called atypical polypoid granular cell tumor). Report of 2 cases with immunohistochemical and ultrastructural correlation.
    Am J Dermatopathol, 30(2): 156-9. [Abstract] [Full-text]
58. Mycosis fungoides after solid-organ transplantation: report of 2 new cases.
    Am J Dermatopathol, 30(2): 150-5. [Abstract] [Full-text]
59. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Am J Dermatopathol, 30(2): 127-34. [Abstract] [Full-text]
60. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Am J Dermatopathol, 30(2): 123-6. [Abstract] [Full-text]
61. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Am J Dermatopathol, 30(2): 117-22. [Abstract] [Full-text]
62. Vascular changes in merkel cell carcinoma based on a histopathological study of 92 cases.
    Am J Dermatopathol, 30(2): 106-11. [Abstract] [Full-text]
63. Do nonmelanoma skin cancers develop from extra-cutaneous stem cells?
    Int J Cancer, 122(10): 2173-7. [Abstract] [Full-text]
64. Cutaneous human papillomavirus infection, the EVER2 gene and incidence of squamous cell carcinoma: a case-control study.
    Int J Cancer, 122(10): 2377-9. [Abstract] [Full-text]
65. Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).
    Ann Oncol, 19(4): 801-6. [Abstract] [Full-text]
66. Desmoplastic melanoma: the role of radiotherapy in improving local control.
    ANZ J Surg, 78(4): 273-6. [Abstract] [Full-text]
67. Tanning and cutaneous malignancy.
    Dermatol Surg, 34(4): 460-74. [Abstract] [Full-text]
68. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer.
    Dermatol Surg, 34(4): 483-97. [Abstract] [Full-text]
69. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
    Dermatol Surg, 34(4): 498-500. [Abstract] [Full-text]
70. Treatment of transformed mycosis fungoides with intermittent low-dose gemcitabine.
    Oncology, 73(1): 130-5. [Abstract] [Full-text]
71. Interleukin-2-based biochemotherapy for patients with stage IV melanoma: long-term survivors outside a clinical trial setting.
    Oncology, 73(1): 33-40. [Abstract] [Full-text]

© 2004-2008 Skin Cancer Research Today. All Rights Reserved.